You are here

  • Home
  • Archive
  • Volume 12, Issue 7
  • Rapid regression of neurological symptoms in patients with metastasised ALK+ lung cancer who are treated with lorlatinib: a report of two cases

Article metrics

Article menu

Download PDFPDF

XML
Novel treatment (new drug/intervention; established drug/procedure in new situation)
CASE REPORT
Rapid regression of neurological symptoms in patients with metastasised ALK+ lung cancer who are treated with lorlatinib: a report of two cases

 

Online download statistics by month:

Online download statistics by month: July 2019 to April 2024

AbstractFullPdf
Jul 201923723227
Aug 201949248629
Sep 201937937920
Oct 201913513318
Nov 2019524824
Dec 201940398
Jan 2020656423
Feb 2020373710
Mar 202041409
Apr 2020393910
May 2020484817
Jun 2020515012
Jul 2020383610
Aug 2020333211
Sep 202045429
Oct 2020444022
Nov 2020403911
Dec 2020424117
Jan 2021424225
Feb 2021292813
Mar 202145457
Apr 202133328
May 2021353510
Jun 202145429
Jul 2021454116
Aug 2021717112
Sep 2021565544
Oct 2021434324
Nov 2021565324
Dec 202134346
Jan 202231303
Feb 2022444420
Mar 202234318
Apr 202244436
May 2022474425
Jun 2022303011
Jul 202236369
Aug 2022293014
Sep 2022333237
Oct 202232325
Nov 2022333517
Dec 202230283
Jan 202324237
Feb 202339406
Mar 2023373117
Apr 202319189
May 202325259
Jun 202321215
Jul 202330307
Aug 202316147
Sep 202313104
Oct 202317175
Nov 202324245
Dec 202325226
Jan 202412124
Feb 202434268
Mar 2024353511
Apr 2024986
Total31953117759